GeneBioTech Co. Ltd (086060) — Long-term Investment Intensity

Latest as of December 2019: 4.6%

GeneBioTech Co. Ltd (086060) has a Long-term Investment Intensity of 4.6% as of December 2019. Long-term investments of ₩3.11 Billion represent 4.6% of total assets of ₩67.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GeneBioTech Co. Ltd (086060) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

4.6%
LT Investments / Total Assets

Long-term Investments

₩3.11 Billion
KRW

Total Assets

₩67.93 Billion
KRW

Country

Korea
KQ

GeneBioTech Co. Ltd Long-term Investment Intensity (2014–2019)

This chart shows how GeneBioTech Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 4.6%, reflecting long-term investments of ₩3.11 Billion against total assets of ₩67.93 Billion KRW. For the complete balance sheet picture, see GeneBioTech Co. Ltd (086060) total assets.

Annual Long-term Investment Intensity for GeneBioTech Co. Ltd (2014–2019)

The table below presents the year-by-year Long-term Investment Intensity for GeneBioTech Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of GeneBioTech Co. Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 4.6% ₩3.11 Billion ₩67.93 Billion ▼ -1.8 pp
2018 6.4% ₩4.64 Billion ₩72.63 Billion ▼ -7.6 pp
2017 14.0% ₩8.31 Billion ₩59.54 Billion ▼ -2.0 pp
2016 16.0% ₩9.46 Billion ₩59.16 Billion ▲ +14.8 pp
2015 1.2% ₩591.75 Million ₩49.21 Billion ▼ -0.5 pp
2014 1.7% ₩787.96 Million ₩47.34 Billion
pp = percentage points